Kronos Early Estrogen Prevention Study (KEEPS)

Trial Profile

Kronos Early Estrogen Prevention Study (KEEPS)

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Apr 2018

At a glance

  • Drugs Conjugated estrogens (Primary) ; Estradiol (Primary) ; Progesterone; Progesterone
  • Indications Atherosclerosis; Menopausal syndrome
  • Focus Therapeutic Use
  • Acronyms KEEPS; KEEPS-CA
  • Most Recent Events

    • 17 Apr 2018 Results (n=75) of a study assessing longitudinal changes in structural brain MRI and global cognitive function 3 years after the end of mHT in KEEPS and the association of these findings with beta amyloid load on PET published in the Neurology
    • 28 Aug 2017 Results (n=670) of ancillary study assessing effects of oral or transdermal estrogen therapy on sexual function in postmenopausal women published in the JAMA Internal Medicine
    • 20 Jul 2017 Results related to brain volume was presented at the Alzheimer's Association International Conference 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top